Next Article in Journal
Comparison of the Incorporation of DHA in Circulatory and Neural Tissue When Provided as Triacylglycerol (TAG), Monoacylglycerol (MAG) or Phospholipids (PL) Provides New Insight into Fatty Acid Bioavailability
Next Article in Special Issue
An Overview of Whole Grain Regulations, Recommendations and Research across Southeast Asia
Previous Article in Journal
Insulin Sensitivity and Glucose Homeostasis Can Be Influenced by Metabolic Acid Load
Article Menu
Issue 5 (May) cover image

Export Article

Open AccessReview
Nutrients 2018, 10(5), 619; https://doi.org/10.3390/nu10050619

Buckwheat and CVD Risk Markers: A Systematic Review and Meta-Analysis

Human Nutrition Research Centre, Institute of Cellular Medicine, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne NE2 4HH, UK
*
Author to whom correspondence should be addressed.
Received: 18 March 2018 / Revised: 9 May 2018 / Accepted: 10 May 2018 / Published: 15 May 2018
(This article belongs to the Special Issue Whole Grains and Human Health)
Full-Text   |   PDF [1654 KB, uploaded 15 May 2018]   |  

Abstract

The effects of buckwheat intake on cardiovascular diseases (CVDs) have not been systematically investigated. The aim of the present study was to comprehensively summarize studies in humans and animals, evaluating the impact of buckwheat consumption on CVD risk markers and to conduct a meta-analysis of relevant data. Thirteen randomized, controlled human studies, two cross-sectional human studies and twenty-one animal studies were identified. Using random-effects models, the weighted mean difference of post-intervention concentrations of blood glucose, total cholesterol and triglycerides were significantly decreased following buckwheat intervention compared with controls [differences in blood glucose: −0.85 mmol/L (95% CI: −1.31, −0.39), total cholesterol: 0.50 mmol/L (95% CI: −0.80, −0.20) and triglycerides: 0.25 mmol/L (95% CI: −0.49, −0.02)]. Responses of a similar magnitude were seen in two cross-sectional studies. For animal studies, nineteen of twenty-one studies showed a significant reduction in total cholesterol of between 12% and 54%, and fourteen of twenty studies showed a significant reduction in triglycerides of between 2% and 74%. All exhibited high unexplained heterogeneity. There was inconsistency in HDL cholesterol outcomes in both human and animal studies. It remains unclear whether increased buckwheat intake significantly benefits other markers of CVD risk, such as weight, blood pressure, insulin, and LDL-cholesterol, and underlying mechanisms responsible for any effects are unclear. View Full-Text
Keywords: buckwheat; CVD risk markers; meta-analysis buckwheat; CVD risk markers; meta-analysis
Figures

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).
SciFeed

Share & Cite This Article

MDPI and ACS Style

Li, L.; Lietz, G.; Seal, C. Buckwheat and CVD Risk Markers: A Systematic Review and Meta-Analysis. Nutrients 2018, 10, 619.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Nutrients EISSN 2072-6643 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top